Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Journal of Neuro-Oncology|November 17, 2023
The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastomaNan Qin, Eunice Paisana, Daniel Picard, et al.
Endocrine-Related Cancer|April 30, 2020
Mass spectrometry-based steroid profiling in primary bilateral macronodular adrenocortical hyperplasiaFady Hannah-Shmouni, Annabel Berthon, Fabio R Faucz, et al.
Journal of the Endocrine Society|August 15, 2024
Identification of Succinate Dehydrogenase Gene Variant Carriers by Blood BiomarkersMarcel Gebhardt, Carola Kunath, Dennis Fröbel, et al.
Scientific Reports|January 8, 2025
Effects of time-of-day on the noradrenaline, adrenaline, cortisol and blood lipidome response to an ice bathAlexander Braunsperger, Maximilian Bauer, Chaima Ben Brahim, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 22, 2020
Mass spectrometry reveals misdiagnosis of primary aldosteronism with scheduling for adrenalectomy due to immunoassay interferenceGeorgiana Constantinescu, Martin Bidlingmaier, Matthias Gruber, et al.
International Journal of Obesity (2005)|May 3, 2018
Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumoursYaxin An, Manja Reimann, Jimmy Masjkur, et al.
NPJ Digital Medicine|June 24, 2026
Advanced machine learning-based screening for primary aldosteronism with plasma steroids, potassium, and reninWenyu Zhang, Christina Pamporaki, René Jäkel, et al.
The Journal of Clinical Endocrinology and Metabolism|October 19, 2021
Plasma Steroid Profiling in Patients With Adrenal IncidentalomaKristina Berke, Georgiana Constantinescu, Jimmy Masjkur, et al.
Hypertension (Dallas, Tex. : 1979)|July 31, 2024
Steroidomics-Based Screening for Primary Aldosteronism: Impact of antihypertensive DrugsGeorgiana Constantinescu, Sven Gruber, Sybille Fuld, et al.
Pageof 15